| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57ccdb0f181d80e5c2199b5823285d67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate |
2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91c46f91a6a9b974fcece56e1352f7c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17651049093ddc2f7a9bf381b2ebba47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb0d6357abe2ac8c9649fc35e3e523b |
| publicationDate |
2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017189380-A1 |
| titleOfInvention |
Tryptamine-based ship inhibitors for the treatment of cancer |
| abstract |
The present disclosure provides compositions that inhibit the SH2-containing inositol 5′-phosphatase (SHIP), as well as methods using such compositions for use in treating or ameliorating the effects of a medical condition in a subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020081852-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019234189-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020028552-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022023315-A1 |
| priorityDate |
2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |